Special Offer for Online Readers

Would you like to add this to your personal library?

Choose from Print, PDF, or both
BUY NOW
Questions? Call 888-624-8373

PAPERBACK + PDF
your price: $53.00
add to cart

PAPERBACK
list:$44.95
Web:$40.46
add to cart

HARDBACK
list:$64.95
Web:$58.46
add to cart

PDF BOOK
your price: $34.50
add to cart

PDF CHAPTERS
your price: $2.40
select

Rights & Permissions

Related Titles

topleft topright

Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids (2000)
Institute of Medicine (IOM)

Page
36
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


DRI DIETARY REFERENCE INTAKES FOR Vitamin C, Vitamin E, Selenium, and Carotenoids

TABLE 2-1 Intervention Trials: Antioxidants and Chronic Diseases

Study

Country

Study Typea

Study Population

Skin Cancer Prevention Study (Greenberg et al., 1990)

U.S.c

Secondary prevention; randomized, double-blind, placebo-controlled intervention

1,805 men and women with recent nonmelanoma skin cancer; aged 40–89 y

Linxian Cancer Prevention Study (Blot et al., 1993)

China

Primary prevention; randomized, double-blind, placebo-controlled intervention

29,584 poorly nourished men and women, aged 40–69 y

α-Tocopherol, β-Carotene Cancer Prevention Study (ATBC Cancer Prevention Group, 1994)

Finland

Primary prevention; randomized, double-blind, placebo-controlled intervention

29,133 male cigarette smokers, aged 50–69 y

Polyp Prevention Study (Greenberg et al., 1994)

U.S.

Secondary prevention; randomized, double-blind, placebo-controlled intervention

864 men and women with recent nonmelanoma skin cancer

The β-Carotene and Retinol Efficacy Trial (Omenn et al., 1996)

U.S.

Primary prevention; randomized, double-blind, placebo-controlled intervention

14,254 heavy smokers and 4,060 asbestos workers, aged 45–69 y

Cambridge Heart Antioxidant Study (Stephens et al., 1996)

U.K.e

Secondary prevention; randomized, double-blind, placebo-controlled intervention

2,002 patients with coronary atherosclerosis, mean age 62 y

Page
36